RMD ResMed Inc.

NYSE · US · Healthcare · Medical Instruments & Supplies · resmed.com

222.86USD+1.81%Mkt Cap: 31.34B $P/E: 21.371d ago

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap31.34B USD

Enterprise Value30.93B USD

Revenue (TTM)5.65B USD

Gross Profit3.45B USD

Net Income (TTM)1.52B USD

Revenue/Share38.85 USD

Last Price222.86 USD

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees11.4K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)21.37

P/E (Forward)16.54

PEG1.27

EV/EBITDA14.76

EV/Revenue5.47

P/S5.45

P/B4.79

EPS (TTM)10.43

EPS (Forward)13.23

52W Range

180.2641% of range284.87

52W High284.87 USD

52W Low180.26 USD

Profitability

Gross Margin61.06%

Oper. Margin30.86%

EBITDA Margin37.07%

Profit Margin26.94%

ROE23.13%

ROA16.99%

Growth

Revenue Growth8.60%

Earnings Growth2.40%

Cash Flow & Leverage

Operating CF1.81B USD

CapEx (TTM)177.17M USD

FCF Margin16.61%

FCF Yield3.00%

Net Debt-643.32M USD

Net Debt/EBITDA-0.31

Balance Sheet

Debt/Equity0.13

Current Ratio3.10

Quick Ratio1.83

Book Value/Sh45.66 USD

Cash/Share10.19 USD

Dividends

Fwd Div Rate2.64 USD

Trail. Div Rate2.40 USD

Div. Yield1.21%

5Y Avg Yield0.86%

Payout Ratio23.01%

Ex-Div DateAug 20, 2026

Pay DateSep 24, 2026

Splits

Last Split2:1

Split DateAug 31, 2010

Analyst Consensus

Rating2.3 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)250.22 USD

Upside (mean)+12.3%

Target Range175.00 USD – 320.00 USD

175.00+12.3% to mean320.00

# Analysts17

Ownership

Shares Out.140.64M

Float143.34M

Insiders0.50%

Institutions71.17%

Short Interest

Short Ratio10.6d

Short % Float11.35%

Short % Out.9.85%

Shares Short14.20M

Short (prev mo.)12.79M

Technical

SMA 50223.26 (-0.2%)

SMA 200225.71 (-1.3%)

Beta0.77

S&P 52W Chg14.58%

Avg Vol (30d)1.18M

Avg Vol (10d)1.01M

Technical Indicators

RSI (14)49.7

MACD-0.7370

MACD Signal-0.1806

MACD Hist.-0.5564

BB Upper228.78 USD

BB Middle222.68 USD

BB Lower216.59 USD

BB Width5.47%

ATR (14)5.379 USD

Vol Ratio (20d)0.82x